1-(hydroxyalkyl)-25-hydroxyvitamin D3 analogs of calcitriol. 1. Synthesis

This publication has 38 references indexed in Scilit:

• Demonstration of a 1,25-dihydroxyvitamin D3-responsive protein in human lymphocytes: immunologic crossreactivity and inverse regulation with the vitamin D receptor.
  Proceedings of the National Academy of Sciences, 1991
• Enhancement of human immunodeficiency virus 1 replication in monocytes by 1,25-dihydroxycholecalciferol.
  Proceedings of the National Academy of Sciences, 1991
• Stereocontrolled synthesis of a trihydroxylated A ring as an immediate precursor to 1.alpha.,2.alpha.,25-trihydroxyvitamin D3
  The Journal of Organic Chemistry, 1991
• 1α,25-Dihydroxyvitamin D3 inhibits productive infection of human monocytes by HIV-1
  Biochemical and Biophysical Research Communications, 1991
• 1,25-Dihydroxy-16-ene-23-yne-vitamin D3 prolongs survival time of leukemic mice.
  Proceedings of the National Academy of Sciences, 1990
• Treatment of psoriasis by the topical application of the novel cholecalciferol analogue calcipotriol (MC 903)
  Archives of Dermatology, 1989
• The Role of the Vitamin D Endocrine System in Health and Disease
  New England Journal of Medicine, 1989
• Systemic Effects of Vitamin D
  Annual Review of Medicine, 1989
• Cultured psoriatic fibroblasts from involved and uninvolved sites have a partial but not absolute resistance to the proliferation-inhibition activity of 1,25-dihydroxyvitamin D3.
  Proceedings of the National Academy of Sciences, 1985
• Differentiation of mouse myeloid leukemia cells induced by 1 alpha,25-dihydroxyvitamin D3.
  Proceedings of the National Academy of Sciences, 1981